Compagnie Lombard Odier SCmA’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,525
Closed -$50K 663
2021
Q1
$50K Hold
2,525
﹤0.01% 507
2020
Q4
$52K Hold
2,525
﹤0.01% 429
2020
Q3
$66K Buy
+2,525
New +$66K ﹤0.01% 358